80 FR 51571 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 164 (August 25, 2015)

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting September 9-10, 2015. The meeting is open to the public. However, pre- registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Participants may also register by emailing [email protected] or by calling 202-690-5566 and providing their name, organization, and email address.

[Federal Register Volume 80, Number 164 (Tuesday, August 25, 2015)]
[Notices]
[Pages 51571-51572]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-20943]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
September 9-10, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/. Participants may also register by emailing 
[email protected] or by calling 202-690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on September 9-10, 2015. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    During the September NVAC meeting, the Committee will hear updates 
on a number of Departmental and stakeholder activities that are working 
to strengthen our national immunization system. The Committee will hear 
an update on progress towards the Healthy People 2020 immunization 
goals, followed by presentations specifically examining progress 
towards the Healthy People 2020 goal to achieve 90% influenza 
vaccination coverage among healthcare personnel. In particular, the 
Committee will look at challenges and opportunities for helping improve 
influenza vaccination among healthcare personnel in long-term care 
settings.
    The Committee also will hear about efforts to support global 
immunization including an introduction to a number of global 
immunization strategies currently under development such as an update 
to the CDC's Global Immunization Strategic Framework, the newly 
established USAID Immunization Blueprint for Action, and the Pan 
American Health Organization's proposed Regional Plan of Action on 
Immunization. In addition, the NVAC will hear a brief overview 
describing the success of efforts to develop the first Ebola vaccine.
    The Committee will be presented with information on how data on 
state exemption laws is collected and used to inform studies on 
vaccination coverage and vaccine acceptance in specific populations. 
NVAC will also host a session continuing their discussions on vaccine 
confidence that will include

[[Page 51572]]

studies looking at how attitudes and beliefs about immunizations change 
over time. Finally, the Committee will be provided with information on 
local and federal efforts to help increase vaccine confidence in 
communities. More information on the meeting agenda will be posted 
prior to the meeting on the NVAC Web site: http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.

    Dated: August 17, 2015.
Jennifer L. Gordon,
Alternate Designated Federal Official, National Vaccine Advisory 
Committee, National Vaccine Program Office.
[FR Doc. 2015-20943 Filed 8-24-15; 8:45 am]
 BILLING CODE 4150-44-P